Dr. Hemant Khandare

AREA(S) OF INTEREST:

PET & SPECT imaging, Nuclear Oncology, Nuclear Neurology, Radioiodine Therapy for Carcinoma Thyroid & Hyperthyroid disorder

PROCEDURES PERFORMED:

PET-CT & Gamma imaging, Radioiodine Therapy, 177Lu- DOTATATE PRRT therapy for Neuroendocrine tumors & 177 Lu-PSMA therapy for Ca Prostate

NAME OF INSTITUTE(S):

• DNB, Jaslok Hospital & Research Institute, Mumbai
• DRM, INHS Navy Hospital, Mumbai
• MBBS, TMC College, New Mumbai

• Executive Member of Association of Nuclear Medicine of India (ANMPI)- 2017-2019, 2019-2021.
• Ex- EC Member- WC SNMI
• Ex- president WC SNMI 2019-2020 & 2021-2022

16 years of clinical experience in Nuclear Medicine from institutes which includes Navy Hospital (INHS Asvini), Jaslok Hospital and Research Centre and Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute.

KDAH Experience:

Dr. Hemant Khandare is working in Kokilaben Dhirubhai Ambani since more than 16 yrs. He has set up Nuclear Medicine facilities of KDAH in 2008-2009. He has performed more than 25000 PET-CT procedures and its reporting and many SPECT procedures and reporting. He has given his great contribution in oncology and Epilepsy by PET-CT and SPECT/PET-MRI fusion techniques. He had treated many Thyroid cancer patients by Radioiodine therapy & NET by PRRT, Ca prostate by PSMA therapy. He also has experience in fusion imaging techniques like PET-CT, SPECT-CT, Brain PET/SPECT and MRI based fusion technique/procedures for localization of seizure focus. He manages Radio-Iodine Therapy for Cancer Thyroid & Thyrotoxicosis Patients, & Bone Palliation Therapy.

Professional Memberships

• Society of Nuclear Medicine of India (SNMI )
• Association of Nuclear Medicine of India (ANMPI )
• Nuclear Cardiology society of India (NCSI )
• Association of Medical consultants (AMC)